目的 探讨阿托伐他汀辅助银杏叶对脑梗死患者颈动脉粥样硬化斑块和脑血流参数的影响。方法 235例脑梗死患者随机分为两组,对照组116例予以阿托伐他汀治疗,实验组119例在对照组治疗的基础上,加用银杏叶制剂。比较两组治疗前后颈动脉粥样硬化斑块、脑血流动力学参数变化,同时记录用药期间不良反应。结果 实验组治疗后血流动力学指标RI(0.52±0.17)、PI(0.91±0.24)低于对照组,Vd(37.29±2.82)cm/s、Vs(81.33±3.58)cm/s、Vm(9.78±1.22)cm/s高于对照组(P＜0.05);实验组治疗后斑块面积(0.52±0.12)cm2、CAIMT(1.26±0.17)mm低于对照组(P＜0.05);两组不良反应率无统计学差异。结论 阿托伐他汀联合银杏叶制剂能够促进脑梗死患者血流动力学参数表达水平的恢复,改善颈动脉粥样硬化斑块,安全性高。
Abstract
Objective To investigate the effect of atovastatin and ginkgo biloba preparations on cerebral blood flow parameters and carotid atherosclerotic plaque indexes in patients with cerebral infarction.Methods Two hundred and thirty-five patients with cerebral infarction were selected in our hospital. The patients were divided into two groups according to the drug regimen. The control group (n=116) was treated with atovastatin while the experimental group (n=119) was additionally given ginkgo biloba preparations. The changes of carotid atherosclerotic plaques, cerebral hemodynamic parameters and hemorheological indexes were compared before and after treatment. Adverse reactions were also recorded.Results In the experimental group, the hemodynamic indexes RI(0.52±0.17) and PI(0.91±0.24) were significantly lower than in the control group, while Vd(37.29±2.82)cm/s, Vs(81.33±3.58)cm/s and Vm(9.78±1.22) cm/s were significantly higher (P＜0.05). In the experimental group, the plaque area of posterior carotid atherosclerosis (0.52±0.12)cm2, CAIMT(1.26±0.17)mm was significantly smaller than that of the control group (P＜0.05) after treatment. There was no significant difference in the rate of adverse reactions between the two groups.Conclusions For patients with cerebral infarction, atovastatin combined with ginkgo biloba preparations can effectively promote the recovery of hemorheological indexes and hemodynamic parameters and improve carotid atherosclerotic plaques. This approach is quite safe.
关键词
阿托伐他汀 /
银杏叶制剂 /
脑梗死 /
脑血流参数 /
颈动脉粥样硬化斑块
Key words
atovastatin /
ginkgo biloba preparation /
cerebral infarction /
cerebral blood flow parameter /
carotid atherosclerotic plaque index
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 刘绪宏,许笑天,祝 峰,等.脉血康胶囊对急性脑梗死患者血管内皮功能及神经功能评分的影响[J].武警医学,2016,27(3):297-299.
[2] 翟卫东,钟建卫,王 涛,等.高血压脑出血并发大面积脑梗死的危险因素分析[J].武警医学,2014,25(5):497-499.
[3] 安占军,徐立霞,曹洁玮.脂微球前列地尔联合依达拉奉治疗急性脑梗死疗效探讨[J].武警医学,2017,28(5):475-477.
[4] 高 见,朱 江,赵 斌.脑梗死患者颈动脉粥样硬化斑块的相关危险因素分析[J].中国实用神经疾病杂志,2014,17(17):71-72.
[5] Yao Q,Zhang C,Zhang X,et al.Synergistic effect of ALOX5AP polymorphisms and cigarette smoking on the risk of atherosclerotic cerebral infarction in a Northern Han Chinese population[J].J Clin Neurosci,2014,21(6):975-979.
[6] 张 斌,王 影,王宝春.颈动脉粥样硬化斑块的彩色多普勒超声表现及其与脑梗死的关系研究[J].现代中西医结合杂志,2017,26(6):663-665.
[7] 齐海英.颈动脉粥样硬化及血流动力学变化与脑梗死的相关性[J].实用临床医药杂志,2015,19(5):127-128.
[8] Naess H,Nyland H I,Thomassen L,et al.Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study[J].Eur J Neurol,2015,11(1):25-30.
[9] 张红伟,王 丹,郝美嘉,等.颈动脉粥样硬化超声检查在脑梗死病人诊治中的应用价值[J].中西医结合心脑血管病杂志,2017,15(10):1241-1243.
[10] 张 超,苗少辉,董 芳.超声波联合普罗布考片对脑梗死患者颈动脉粥样硬化斑块的治疗效果分析[J].检验医学与临床,2017,14(10):1372-1373.
[11] Zhang F,Li X,Dong Q,et al.Risk of acute cerebral infarction and plasma asymmetrical dimethylarginine and homocysteine levels: a clinical correlation analysis of Chinese population[J].J Stroke & Cerebrovascular Dis,2014,23(9):2225-2232.
[12] 贺 曦,张 敏,杨 柳,等.瑞舒伐他汀钙对脑梗死患者动脉粥样硬化及脑血流动力学的改善作用研究[J].检验医学与临床,2016,13(16):2276-2277.
[13] Camerlingo M,Tudose V,Tognozzi M,et al.Predictors of re-canalisation in acute cerebral infarction from occlusion of the terminal internal carotid artery or of the middle cerebral artery mainstem treated with thrombolysis[J].Int J Neurosci,2014,124(3):199-203.
PDF(779 KB)
